Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration.

The development of genotyping technologies has allowed for wider screening for inherited causes of variable outcomes following drug administration. We have performed a genome-wide association study (GWAS) on 221 colorectal cancer (CRC) patients that had been treated with 5-fluorouracil (5-FU), eithe...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit:	Fernandez-Rozadilla, C, Cazier, J, Moreno, V, Crous-Bou, M, Guinó, E, Durán, G, Lamas, M, López, R, Candamio, S, Gallardo, E, Paré, L, Baiget, M, Páez, D, López-Fernández, L, Cortejoso, L, García, M, Bujanda, L, González, D, Gonzalo, V, Rodrigo, L, Reñé, J, Jover, R, Brea-Fernández, A, Andreu, M, Bessa, X
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2013

Pharmacogenomics in colorectal cancer: A genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration Dahkki Fernandez-Rozadilla, C, Cazier, J, Moreno, V, Crous-Bou, M, Guinó, E, Durán, G, Lamas, M, López, R, Candamio, S, Gallardo, E, Paré, L, Baiget, M, Páez, D, López-Fernández, L, Cortejoso, L, García, M, Bujanda, L, González, D, Gonzalo, V, Rodrigo, L, Reñé, J, Jover, R, Brea-Fernández, A, Andreu, M, Bessa, X

Almmustuhtton 2013

Journal article

Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration.

Geahča maid